St. Luke's Cancer Center — Bethlehem, Pennsylvania

St. Luke's Cancer Center is a clinical research site located in Bethlehem, Pennsylvania, United States 18015.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

St. Luke's Cancer Center has participated in 4 clinical trials.

Therapeutic areas: Melanoma, Pancreatic Cancer, Metastatic Pancreatic Cancer.

Sponsors: Genta Incorporated, SciClone Pharmaceuticals, Peregrine Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Luke's Cancer Center?

St. Luke's Cancer Center has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Luke's Cancer Center conducted?

St. Luke's Cancer Center has 4 clinical trials on record. Their work covers Melanoma, Pancreatic Cancer, Metastatic Pancreatic Cancer.

Is St. Luke's Cancer Center accredited by Crixeo Health?

St. Luke's Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about St. Luke's Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.